Human Natural Killer Cell Maturation Defect Supports In Vivo CD56bright to CD56dim Lineage Development

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Domaica, Carolina Inés ^a   Fuertes, Mercedes Beatriz ^a,b   Uriarte, Ignacio ^c   Girart, María Victoria ^a   Sardañons, Jessica ^c   Comas, Dorina Ileana ^c   Di Giovanni, Daniela ^c   Gaillard, María Isabel ^c   Bezrodnik, Liliana ^c   Zwirner, Norberto Walter ^a,b  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CD158 ANTIGEN; CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD94 ANTIGEN; CELL ANTIGEN; CELL PROTEIN; GAMMA INTERFERON; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; PERFORIN; PROTEIN 2B4; PROTEIN DNAM 1; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIGEN EXPRESSION; ARTICLE; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RESPONSE; DOWN REGULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE SUBPOPULATION; MELANOMA; NATURAL KILLER CELL; OPPORTUNISTIC INFECTION; PHENOTYPIC VARIATION; PROTEIN EXPRESSION; UPREGULATION;

ANTIGENS, CD56; CELL DIFFERENTIATION; CELL LINEAGE; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; K562 CELLS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR;

EID: 84871174180     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051677     Document Type: Article

References (35)

1. Ferlazzo G, Pack M, Thomas D, Paludan C, Schmid D, et al. (2004) Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci U S A 101: 16606-16611.
2. Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, et al. (1999) Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5: 405-411.
3. Zwirner NW, Domaica CI, (2010) Cytokine regulation of natural killer cell effector functions. Biofactors 36: 274-288.
4. Lanier LL, (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9: 495-502.
5. Moretta A, Marcenaro E, Parolini S, Ferlazzo G, Moretta L, (2008) NK cells at the interface between innate and adaptive immunity. Cell Death Differ 15: 226-233.
6. Caligiuri MA, (2008) Human natural killer cells. Blood 112: 461-469.
7. Strowig T, Brilot F, Munz C, (2008) Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity. J Immunol 180: 7785-7791.
8. Frey M, Packianathan NB, Fehniger TA, Ross ME, Wang WC, et al. (1998) Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J Immunol 161: 400-408.
9. Orange JS, (2006) Human natural killer cell deficiencies. Curr Opin Allergy Clin Immunol 6: 399-409.
10. Poli A, Michel T, Theresine M, Andres E, Hentges F, et al. (2009) CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 126: 458-465.
11. Vitale C, Chiossone L, Morreale G, Lanino E, Cottalasso F, et al. (2005) Human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation: analysis of the surface expression and function of activating NK receptors. Mol Immunol 42: 405-411.
12. Freud AG, Yokohama A, Becknell B, Lee MT, Mao HC, et al. (2006) Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med 203: 1033-1043.
13. Chan A, Hong DL, Atzberger A, Kollnberger S, Filer AD, et al. (2007) CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J Immunol 179: 89-94.
14. De Maria A, Bozzano F, Cantoni C, Moretta L, (2011) Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation. Proc Natl Acad Sci U S A 108: 728-732.
15. Fehniger TA, Cooper MA, Nuovo GJ, Cella M, Facchetti F, et al. (2003) CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101: 3052-3057.
16. Romagnani C, Juelke K, Falco M, Morandi B, D'Agostino A, et al. (2007) CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J Immunol 178: 4947-4955.
17. Vitale M, Della Chiesa M, Carlomagno S, Romagnani C, Thiel A, et al. (2004) The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur J Immunol 34: 1715-1722.
18. Warren HS, Kinnear BF, Kastelein RL, Lanier LL, (1996) Analysis of the costimulatory role of IL-2 and IL-15 in initiating proliferation of resting (CD56dim) human NK cells. J Immunol 156: 3254-3259.
19. Bjorkstrom NK, Ljunggren HG, Sandberg JK, (2010) CD56 negative NK cells: origin, function, and role in chronic viral disease. Trends Immunol 31: 401-406.
20. Zimmer J, Bausinger H, Andres E, Donato L, Hanau D, et al. (2007) Phenotypic studies of natural killer cell subsets in human transporter associated with antigen processing deficiency. PloS One 2: e1033.
21. Villa-Forte A, de la Salle H, Fricker D, Hentges F, Zimmer J, (2008) HLA class I deficiency syndrome mimicking Wegener's granulomatosis. Arthritis Rheum 58: 2579-2582.
22. Bielekova B, Catalfamo M, Reichert-Scrivner S, Packer A, Cerna M, et al. (2006) Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci U S A 103: 5941-5946.
23. Li Z, Lim WK, Mahesh SP, Liu B, Nussenblatt RB, (2005) In vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis. J Immunol 174: 5187-5191.
24. Barcelos W, Sathler-Avelar R, Martins-Filho OA, Carvalho BN, Guimaraes TM, et al. (2008) Natural killer cell subpopulations in putative resistant individuals and patients with active Mycobacterium tuberculosis infection. Scand J Immunol 68: 92-102.
25. Gineau L, Cognet C, Kara N, Lach FP, Dunne J, et al. (2012) Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. J Clin Invest 122: 821-832.
26. Hughes CR, Guasti L, Meimaridou E, Chuang CH, Schimenti JC, et al. (2012) MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. J Clin Invest 122: 814-820.
27. Beziat V, Descours B, Parizot C, Debre P, Vieillard V, (2010) NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PloS One 5: e11966.
28. Bjorkstrom NK, Riese P, Heuts F, Andersson S, Fauriat C, et al. (2010) Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116: 3853-3864.
29. Lopez-Verges S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, et al. (2010) CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 116: 3865-3874.
30. Sun JC, Lopez-Verges S, Kim CC, De Risi JL, Lanier LL, (2011) NK cells and immune "memory". J Immunol 186: 1891-1897.
31. Beziat V, Duffy D, Quoc SN, Le Garff-Tavernier M, Decocq J, et al. (2011) CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation. J Immunol 186: 6753-6761.
32. Dulphy N, Haas P, Busson M, Belhadj S, Peffault de Latour R, et al. (2008) An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. J Immunol 181: 2227-2237.
33. Allan DS, Rybalov B, Awong G, Zuniga-Pflucker JC, Kopcow HD, et al. (2010) TGF-beta affects development and differentiation of human natural killer cell subsets. Eur J Immunol 40: 2289-2295.
34. Smalley DM, Ley K, (2005) L-selectin: mechanisms and physiological significance of ectodomain cleavage. J Cell Mol Med 9: 255-266.
35. Moldovan I, Galon J, Maridonneau-Parini I, Roman Roman S, Mathiot C, et al. (1999) Regulation of production of soluble Fc gamma receptors type III in normal and pathological conditions. Immunol Lett 68: 125-134.